|
 StroFun
Repeater
Registered: 07/11/06
Posts: 977
Loc: Mycotopia.net
|
 The fight for MMJ against out government by Rick Doblin (podcast) 
#6519296 - 02/01/07 09:33 AM (17 years, 2 months ago) |
|
|
http://www.norml.org/audio/audio_stash/interviews/NORML_Interview_Rick_Doblin_Chris_Goldstein.mp3
Can be found in the guest interviews section:
http://www.normlaudiostash.com/archive.htm
This interview explains how the government is stonewalling any attempts to get an FDA approved Medical Marijuana Study in the works and how NIDA has a monopoly on research grade marijuana as told by the founder and director of MAPS, Rick Doblin.
I found this an interesting interview due to the fact that during the '06 ballot initiatives and their debates about those subjects, the proponents of prohibition cite that the FDA does not recognize the medical value of marijuana and therefore marijuana has no accepted medical value.
This isn't the most current news but the lawsuits are ongoing and so is the effort(for 7 years in fact). I believe this is the correct subforum to post this in per the requirements [The submitted news should be related to the scope of this website. (mushrooms, psychedelics, drugs in general, war on drugs, etc....)]
Please listen to this and spread the information.
|
StroFun
Repeater
Registered: 07/11/06
Posts: 977
Loc: Mycotopia.net
|
Re: The fight for MMJ against out government by Rick Doblin (podcast) [Re: StroFun]
#6557431 - 02/12/07 08:57 AM (17 years, 2 months ago) |
|
|
From MAPS.org:
No Ruling Yet in DEA Lawsuit for MAPS-Sponsored Medical Marijuana
Production Facility
It has now been more than nine (9) months since lawyers representing
Professor Lyle Craker and the DEA filed final legal briefs in Prof. Craker's
MAPS-supported lawsuit against the DEA. MAPS and Prof. Craker have been
engaged in a six year struggle to end the government monopoly on the supply
of marijuana that can be used in legal FDA research to develop marijuana
into an FDA-approved medicine. Prof. Craker is suing DEA for refusing to
issue him a Schedule I license for a MAPS-sponsored medical marijuana
production facility at the University of Massachusetts-Amherst. Prof. Craker
needs a Schedule I DEA license to grow research-grade marijuana for use by
scientists in MAPS-sponsored and FDA- and DEA-approved studies.
Since we had originally been told that a recommendation from DEA
Administrative Law Judge (ALJ) Mary Ellen Bittner would probably be issued
within 3-6 months, we are still expecting a decision in this case any day.
If the DEA ALJ issues a favorable recommendation, DEA Administrator Karen
Tandy would then need to decide whether to accept or reject the ALJ
recommendation. If DEA accepts a favorable recommendation, Prof. Craker's
proposed MAPS-funded facility would create the necessary independence of
supply outside of the NIDA-controlled monopoly to justify the time and
expense for MAPS and other organizations to sponsor clinical research
evaluating the risks and benefits of marijuana as a potential FDA-approved
prescription medicine.
If there is a favorable recommendation, we're poised for action with the new
Congress, to try to create sufficient pressure on DEA to accept the
recommendation. We'll need all supporters to contact their Congressional
Representatives, so look out for an important announcement sometime soon. If
there is an unfavorable recommendation, we'll do our best to spread the word
that the FDA drug development route is fundamentally obstructed by NIDA's
monoply, stressing even more the need for state and local reforms.
For extensive background information on the case visit:
http://www.maps.org/MOUSewell.htm
|
|
Threaded
Previous
Index
Next
Bulk Cannabis Seeds 
Buy Kratom Extract, Kratom Powder For Sale 
North Spore Mushroom Grow Kits & Cultivation Supplies
Edit 
Reply 
veggie
Mitchnast
motaman
Ravus
Anno
